RO

Regents of the University of California

North America, California, United States, Oakland

Description

The Regents of the University of California is the governing board of the University of California.

Investor Profile

Regents of the University of California has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series E (25%)
  • Series B (25%)
  • Series C (25%)
  • Series D (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Oncology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Regents of the University of California frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 2
Eventide
North America, Massachusetts, United States, Boston
Co-Investments: 1
DC
North America, Illinois, United States, Chicago
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
The Column Group
North America, California, United States, San Francisco
Co-Investments: 4
TV
North America, Texas, United States, Dallas
Co-Investments: 2
Topspin Partners
North America, New York, United States, Mamaroneck
Co-Investments: 3
CV
North America, Texas, United States, Dallas
Co-Investments: 1

Which angels does Regents of the University of California often collaborate with?

JT
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Regents of the University of California?

Rapt Therapeutics

South San Francisco, California, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series CJun 19, 2019
Amount Raised: $37,000,000
Peloton Therapeutics

Dallas, Texas, United States

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics
Series EFeb 20, 2019
Amount Raised: $150,000,000
Peloton Therapeutics

Dallas, Texas, United States

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics
Series DSep 15, 2016
Amount Raised: $52,400,000
Rapt Therapeutics

South San Francisco, California, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Series BApr 26, 2016
Amount Raised: $50,000,000